Eli Lilly (LLY) Intangibles (2010 - 2026)

Eli Lilly (LLY) has 16 years of Intangibles data on file, last reported at $7.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Intangibles rose 22.65% year-over-year to $7.4 billion; the trailing twelve-month figure through Mar 2026 stood at $7.4 billion (up 22.65% YoY), and the FY2025 full-year result was $6.5 billion, up 5.76% from the prior year.
• Intangibles for Q1 2026 stood at $7.4 billion, up from $6.5 billion in the prior quarter.
• Across five years, Intangibles topped out at $7.5 billion in Q2 2022 and bottomed at $5.9 billion in Q2 2025.
• The 5-year median for Intangibles is $6.8 billion (2023), against an average of $6.8 billion.
• The widest annual swing landed in 2025, when Intangibles slipped 11.09%; it then increased 22.65% in 2026.
• A 5-year view of Intangibles shows it stood at $7.2 billion in 2022, then decreased by 4.16% to $6.9 billion in 2023, then slipped by 10.72% to $6.2 billion in 2024, then rose by 5.76% to $6.5 billion in 2025, then advanced by 13.08% to $7.4 billion in 2026.
• The last three Intangibles figures came in at $7.4 billion (Q1 2026), $6.5 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.

Peer Comparison